Table 1.
Clinical and demographic characteristics of patients.
| Sex | Age (years) | Epilepsy etiology | Daily VPA dose (mg/d) | Daily VPA dose (mg/kg) | BMI before treatment (kg/m2) | BMI after treatment (kg/m2) |
|---|---|---|---|---|---|---|
| F | 38 | Gen | 600 | 12.5 | 21.3 | 21.8 |
| F | 38 | Str/met | 900 | 15 | 21.8 | 21.8 |
| M | 21 | Gen | 900 | 8.3 | 34.5 | 34.5 |
| M | 21 | Gen | 600 | 6.9 | 24.1 | 25.5 |
| M | 18 | Gen | 600 | 9.7 | 20.0 | 23.6 |
| F | 21 | Gen | 600 | 12.8 | 17.7 | 18.8 |
| F | 33 | Gen | 600 | 11.8 | 20.2 | 21.0 |
| F | 18 | Gen | 600 | 9.8 | 19.5 | 19.8 |
| F | 32 | Str/met | 1200 | 15.8 | 24.8 | 24.5 |
Gen, genetic; Str/met, structural/metabolic; VPA, valproate; BMI, body mass index.